EZH2 and atherosclerosis: EZH2 reduced ABCA1 expression by promoting triple methylation of lysine 27 (H3K27) in the ABCA1 promoter region and then reduced cholesterol efflux to promote foam cell formation and atherosclerosis development 137, 138.